Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
Clinical trial NCT01968460 · COMPLETED
Trial details
- NCT number
- NCT01968460
- Sponsor
- Pharma Two B Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.